Bionano Genomics, Inc. (BNGO) vs Cosmos Health Inc. (COSM)

A side-by-side comparison of Bionano Genomics, Inc. and Cosmos Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BNGO vs COSM

growth of $100 · dividends reinvested · last 8y
BNGO -100.0% (-62.5%/yr)COSM -99.8% (-54.1%/yr)COSM compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$0$0
BNGO COSM

BNGO vs COSM: by the numbers

  • •COSM is the larger company ($19M vs $17M market cap).
  • •Both run net losses; COSM's is the smaller (-33.08% vs -106.58% net margin).
  • •BNGO grew revenue faster over the past five years (17.97% vs 5.24% CAGR).

Metrics side by side

Valuation

MetricBNGOCOSM
P/S ratio0.550.26
P/B ratio0.520.91

Profitability

MetricBNGOCOSM
Gross margin21.95%10.27%
Operating margin-116.95%-24.65%
Net margin-106.58%-33.08%
ROE-101.76%-117.98%
ROIC-85.72%-46.69%

Growth (annualized)

MetricBNGOCOSM
Revenue CAGR (5Y)17.97%5.24%
Total return CAGR (5Y)-78.37%-68.41%

Frequently asked

Which has grown faster, BNGO or COSM?
Over the past five years, BNGO grew revenue faster — BNGO at a 17.97% CAGR versus COSM at 5.24%.
How have BNGO and COSM total returns compared?
Over the past 5 years, BNGO delivered -78.37% and COSM delivered -68.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.